Due to the prognostic role of EGFR and the relevance of determination the EGFR expression status as well as the identification of EGFR mutations to select individual therapies for lung cancer patients, the evaluation of lung carcinomas require the optimal characterization of clinical sections in routine histopathology. Here, EGFR is linked to lung carcinoma.